Praxis precision medicines provides corporate update and reports fourth quarter and full year 2020 financial results

Prax-114 phase 2/3 clinical trial for treatment of mdd to initiate in march 2021 following ind clearance

PRAX Ratings Summary

PRAX Quant Ranking